Takeda Pharmaceuticals North America Inc. in April will begin selling a new pill to treat high blood pressure after the Food and Drug Administration approved the Deerfield-based company’s Edarbi tablets, the agency said.
Edarbi, which will cost about $75 for a month’s supply, enters a crowded field of blood pressure medications, including several cheaper generics that employers and consumer groups say work well and can cost pennies a day. Get the full story »
